Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ophthalmic drugs are extensively used to treat glaucoma, cataract, and other ophthalmic disorders. The introduction of new ocular drug delivery methods on the market has led manufacturers to develop innovative treatments for the treatment of ophthalmic diseases.
The prevalence of eye-related diseases and disorders, as well as the incidence of chronic diseases affecting vision, such as neurovascular disease or diabetes, is increasing. The global Ophthalmic Drugs market is expected to register 5.3% CAGR during the forecast period of 2020 to 2026.
The main factors contributing to the growth of the Ophthalmic Drugs market include the increase in the incidence and prevalence of ocule-related diseases, the increase in research and development activities related to the development of new drugs and the increasing focus on the development of combination therapies. Additionally, the increasing investments in developing novel drugs and an increase in the funding for research on ophthalmic drugs are driving the Ophthalmic Drugs market.
The report details the trend, potential and market size of Ophthalmic Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Ophthalmic Drugsmarket, defines the market attractiveness level of Ophthalmic Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Ophthalmic Drugs industry, describes the types of Ophthalmic Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ophthalmic Drugs market and the development prospects and opportunities of Ophthalmic Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ophthalmic Drugs market in Chapter 13.
By Player:
Sun Pharmaceutical Industries
Santen Pharmaceutical
Pfizer
Bausch and Lomb
Shire
Novartis
Regeneron Pharmaceuticals
Johnson and Johnson
Actavis Generics
Allergan
Valeant Pharmaceuticals
Genentech
By Type:
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
By End-User:
Hospital
Clinic
Pharmacy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Ophthalmic Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Ophthalmic Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Ophthalmic Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Ophthalmic Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Ophthalmic Drugs Market Analysis and Outlook to 2022
-
7.1 Global Ophthalmic Drugs Consumption (2017-2022)
-
7.2 United States Ophthalmic Drugs Consumption (2017-2022)
-
7.3 Europe Ophthalmic Drugs Consumption (2017-2022)
-
7.4 China Ophthalmic Drugs Consumption (2017-2022)
-
7.5 Japan Ophthalmic Drugs Consumption (2017-2022)
-
7.6 India Ophthalmic Drugs Consumption (2017-2022)
-
7.7 South Korea Ophthalmic Drugs Consumption (2017-2022)
8 Region and Country-wise Ophthalmic Drugs Market Analysis and Outlook to 2028
-
8.1 Global Ophthalmic Drugs Consumption Forecast (2022-2028)
-
8.2 United States Ophthalmic Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Ophthalmic Drugs Consumption Forecast (2022-2028)
-
8.4 China Ophthalmic Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Ophthalmic Drugs Consumption Forecast (2022-2028)
-
8.6 India Ophthalmic Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Ophthalmic Drugs Consumption Forecast (2022-2028)
9 Global Ophthalmic Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Ophthalmic Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anti-allergy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anti-VEGF Agents Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Anti-inflammatory Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Anti-glaucoma Consumption and Growth Rate (2017-2022)
-
9.2 Global Ophthalmic Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Pharmacy Consumption and Growth Rate (2017-2022)
10 Global Ophthalmic Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Ophthalmic Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anti-allergy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Anti-VEGF Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Anti-inflammatory Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Anti-glaucoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Ophthalmic Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
11 Global Ophthalmic Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Ophthalmic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Ophthalmic Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Ophthalmic Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Ophthalmic Drugs Market Competitive Analysis
-
14.1 Sun Pharmaceutical Industries
-
14.1.1 Sun Pharmaceutical Industries Company Details
-
14.1.2 Sun Pharmaceutical Industries Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sun Pharmaceutical Industries Ophthalmic Drugs Product and Service
-
14.2 Santen Pharmaceutical
-
14.2.1 Santen Pharmaceutical Company Details
-
14.2.2 Santen Pharmaceutical Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Santen Pharmaceutical Ophthalmic Drugs Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Ophthalmic Drugs Product and Service
-
14.4 Bausch and Lomb
-
14.4.1 Bausch and Lomb Company Details
-
14.4.2 Bausch and Lomb Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bausch and Lomb Ophthalmic Drugs Product and Service
-
14.5 Shire
-
14.5.1 Shire Company Details
-
14.5.2 Shire Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Shire Ophthalmic Drugs Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Ophthalmic Drugs Product and Service
-
14.7 Regeneron Pharmaceuticals
-
14.7.1 Regeneron Pharmaceuticals Company Details
-
14.7.2 Regeneron Pharmaceuticals Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Regeneron Pharmaceuticals Ophthalmic Drugs Product and Service
-
14.8 Johnson and Johnson
-
14.8.1 Johnson and Johnson Company Details
-
14.8.2 Johnson and Johnson Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Johnson and Johnson Ophthalmic Drugs Product and Service
-
14.9 Actavis Generics
-
14.9.1 Actavis Generics Company Details
-
14.9.2 Actavis Generics Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Actavis Generics Ophthalmic Drugs Product and Service
-
14.10 Allergan
-
14.10.1 Allergan Company Details
-
14.10.2 Allergan Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Allergan Ophthalmic Drugs Product and Service
-
14.11 Valeant Pharmaceuticals
-
14.11.1 Valeant Pharmaceuticals Company Details
-
14.11.2 Valeant Pharmaceuticals Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Valeant Pharmaceuticals Ophthalmic Drugs Product and Service
-
14.12 Genentech
-
14.12.1 Genentech Company Details
-
14.12.2 Genentech Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Genentech Ophthalmic Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Ophthalmic Drugs
-
Figure Ophthalmic Drugs Picture
-
Table Global Ophthalmic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ophthalmic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ophthalmic Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Ophthalmic Drugs Consumption by Country (2017-2022)
-
Figure United States Ophthalmic Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Ophthalmic Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Ophthalmic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Ophthalmic Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Ophthalmic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ophthalmic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Ophthalmic Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Ophthalmic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ophthalmic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Ophthalmic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ophthalmic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ophthalmic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ophthalmic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-allergy Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-VEGF Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-inflammatory Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-glaucoma Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-allergy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-VEGF Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-inflammatory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-glaucoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Ophthalmic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Ophthalmic Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Sun Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Industries Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Industries Ophthalmic Drugs Product and Service
-
Table Santen Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Santen Pharmaceutical Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Santen Pharmaceutical Ophthalmic Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Ophthalmic Drugs Product and Service
-
Table Bausch and Lomb (Foundation Year, Company Profile and etc.)
-
Table Bausch and Lomb Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bausch and Lomb Ophthalmic Drugs Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Ophthalmic Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Ophthalmic Drugs Product and Service
-
Table Regeneron Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Regeneron Pharmaceuticals Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Ophthalmic Drugs Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Ophthalmic Drugs Product and Service
-
Table Actavis Generics (Foundation Year, Company Profile and etc.)
-
Table Actavis Generics Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Generics Ophthalmic Drugs Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Ophthalmic Drugs Product and Service
-
Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceuticals Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals Ophthalmic Drugs Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Ophthalmic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Ophthalmic Drugs Product and Service
-
